Axios @axios
JUST IN: Pfizer and BioNTech's coronavirus vaccine is safe and effective in children ages 5 to 11, albeit at a lower dose than adults receive, the companies said in a press release announcing results from a pediatric trial. https://t.co/NjgM1Xbx7x — PolitiTweet.org